1. Home
  2. SRDX vs FFA Comparison

SRDX vs FFA Comparison

Compare SRDX & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • FFA
  • Stock Information
  • Founded
  • SRDX 1979
  • FFA 2004
  • Country
  • SRDX United States
  • FFA United States
  • Employees
  • SRDX N/A
  • FFA N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • FFA Investment Managers
  • Sector
  • SRDX Health Care
  • FFA Finance
  • Exchange
  • SRDX Nasdaq
  • FFA Nasdaq
  • Market Cap
  • SRDX 415.4M
  • FFA 409.4M
  • IPO Year
  • SRDX 1998
  • FFA N/A
  • Fundamental
  • Price
  • SRDX $30.91
  • FFA $20.73
  • Analyst Decision
  • SRDX Buy
  • FFA
  • Analyst Count
  • SRDX 2
  • FFA 0
  • Target Price
  • SRDX $43.00
  • FFA N/A
  • AVG Volume (30 Days)
  • SRDX 92.6K
  • FFA 26.1K
  • Earning Date
  • SRDX 07-30-2025
  • FFA 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • FFA 6.72%
  • EPS Growth
  • SRDX N/A
  • FFA N/A
  • EPS
  • SRDX N/A
  • FFA N/A
  • Revenue
  • SRDX $121,575,000.00
  • FFA N/A
  • Revenue This Year
  • SRDX N/A
  • FFA N/A
  • Revenue Next Year
  • SRDX $3.70
  • FFA N/A
  • P/E Ratio
  • SRDX N/A
  • FFA N/A
  • Revenue Growth
  • SRDX N/A
  • FFA N/A
  • 52 Week Low
  • SRDX $26.00
  • FFA $15.84
  • 52 Week High
  • SRDX $42.25
  • FFA $19.30
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 65.27
  • FFA 73.24
  • Support Level
  • SRDX $29.51
  • FFA $20.50
  • Resistance Level
  • SRDX $31.06
  • FFA $20.76
  • Average True Range (ATR)
  • SRDX 0.91
  • FFA 0.19
  • MACD
  • SRDX 0.18
  • FFA 0.03
  • Stochastic Oscillator
  • SRDX 86.61
  • FFA 96.03

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

Share on Social Networks: